LEU vs. CORT
LEU (Centrus Energy Corp.) and CORT (Corcept Therapeutics Incorporated) are both stocks. LEU operates in Uranium (Energy), while CORT operates in Biotechnology (Healthcare). Over the past 10 years, LEU returned 46.90%/yr vs 29.33%/yr for CORT. At a 0.12 correlation, their price movements are largely independent.
Performance
LEU vs. CORT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LEU achieves a -32.55% return, which is significantly lower than CORT's 110.72% return. Over the past 10 years, LEU has outperformed CORT with an annualized return of 46.90%, while CORT has yielded a comparatively lower 29.33% annualized return.
LEU
- 1D
- 1.21%
- 1M
- -21.02%
- YTD
- -32.55%
- 6M
- -39.02%
- 1Y
- 14.42%
- 3Y*
- 71.98%
- 5Y*
- 44.90%
- 10Y*
- 46.90%
CORT
- 1D
- 0.98%
- 1M
- 40.26%
- YTD
- 110.72%
- 6M
- -11.63%
- 1Y
- 5.36%
- 3Y*
- 46.50%
- 5Y*
- 27.35%
- 10Y*
- 29.33%
LEU vs. CORT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LEU Centrus Energy Corp. | -32.55% | 264.45% | 22.42% | 67.52% | -34.92% | 115.78% | 236.19% | 307.10% | -57.86% | -37.15% |
CORT Corcept Therapeutics Incorporated | 110.72% | -30.94% | 55.14% | 59.92% | 2.58% | -24.31% | 116.20% | -9.43% | -26.02% | 148.76% |
Correlation
The correlation between LEU and CORT is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Apr 14, 2004 | 0.12 |
The correlation between LEU and CORT shifts across timeframes, from 0.12 (all time) to 0.26 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
LEU:
$3.68B
CORT:
$7.66B
LEU:
$2.89
CORT:
$0.41
LEU:
56.59
CORT:
178.81
LEU:
7.58
CORT:
11.07
LEU:
4.74
CORT:
12.00
LEU:
$452.30M
CORT:
$769.10M
LEU:
$116.10M
CORT:
$755.64M
LEU:
$70.50M
CORT:
$3.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LEU vs. CORT — Risk / Return Rank
LEU
CORT
LEU vs. CORT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Centrus Energy Corp. (LEU) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LEU | CORT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.14 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 0.23 | 0.08 | +0.15 |
| Martin ratioReturn relative to average drawdown | 0.38 | 0.15 | +0.23 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LEU | CORT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.16 | 0.07 | +0.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.52 | 0.37 | +0.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.44 | +0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.10 | 0.11 | -0.21 |
Drawdowns
LEU vs. CORT - Drawdown Comparison
The maximum LEU drawdown since its inception was -99.98%, which is greater than CORT's maximum drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for LEU and CORT.
Loading charts...
Drawdown Indicators
| LEU | CORT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -94.28% | -5.70% |
Max Drawdown (1Y)Largest decline over 1 year | -62.89% | -64.40% | +1.51% |
Max Drawdown (3Y)Largest decline over 3 years | -62.89% | -71.85% | +8.96% |
Max Drawdown (5Y)Largest decline over 5 years | -78.23% | -71.85% | -6.38% |
Max Drawdown (10Y)Largest decline over 10 years | -83.84% | -71.85% | -11.99% |
Current DrawdownCurrent decline from peak | -97.58% | -35.80% | -61.78% |
Average DrawdownAverage peak-to-trough decline | -73.98% | -53.44% | -20.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.75% | 35.34% | +2.41% |
Volatility
LEU vs. CORT - Volatility Comparison
Centrus Energy Corp. (LEU) has a higher volatility of 22.37% compared to Corcept Therapeutics Incorporated (CORT) at 16.41%. This indicates that LEU's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LEU | CORT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.37% | 16.41% | +5.96% |
Volatility (6M)Calculated over the trailing 6-month period | 65.68% | 85.07% | -19.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 91.10% | 76.73% | +14.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 86.24% | 74.52% | +11.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 82.26% | 67.22% | +15.04% |
Dividends
LEU vs. CORT - Dividend Comparison
Neither LEU nor CORT has paid dividends to shareholders.
Financials
LEU vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Centrus Energy Corp. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LEU vs. CORT - Profitability Comparison
LEU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Centrus Energy Corp. reported a gross profit of 31.50M and revenue of 76.70M. Therefore, the gross margin over that period was 41.1%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.
LEU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Centrus Energy Corp. reported an operating income of 800.00K and revenue of 76.70M, resulting in an operating margin of 1.0%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.
LEU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Centrus Energy Corp. reported a net income of 10.00M and revenue of 76.70M, resulting in a net margin of 13.0%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.
Frequently Asked Questions
LEU and CORT have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LEU has higher volatility (22.37%) compared to CORT (16.41%). In terms of maximum drawdown, LEU dropped -99.98% vs CORT's -94.28%.
LEU currently has the higher Sharpe Ratio (0.16 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LEU and CORT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer